Heterozygous nonsense mutation in exon 3 of the growth hormone receptor (GHR) in severe GH insensitivity (Laron syndrome) and the issue of the origin and function of the GHRd3 isoform. 2003

Jacques Pantel, and Jürgen Grulich-Henn, and Markus Bettendorf, and Christian J Strasburger, and Udo Heinrich, and Serge Amselem
Institut National de la Santé et de la Recherche Médicale, Unité-468, Hôpital Henri Mondor, 94010 Créteil, France.

Mutations in the GH receptor gene (GHR) cause congenital GH insensitivity, a genetic disorder characterized by severe growth retardation associated with high serum concentration of GH and low serum levels of IGF-I. Molecular defects have been identified in all GHR-coding exons, except exon 3, a sequence that encodes part of the extracellular domain of the receptor. In humans, GHR transcripts exist in two isoforms differing by the retention (GHRfl) or exclusion (GHRd3) of this particular exon. As shown recently, such a dimorphic expression pattern, of unknown significance, could result from a retrovirus-mediated deletion event involving exon 3. This model for the generation of those two isoforms, however, leaves open the possibility that GHRd3 transcripts also arise from GHRfl alleles through alternative splicing. Here we report the identification of the first mutation in exon 3 of the GHR (W16X) in a patient with GH insensitivity and who also carries another nonsense mutation in exon 4. Intrafamilial correlation analyses of genotypes (presence of normal or mutant GHRfl and/or GHRd3 alleles), GHR expression patterns, and phenotypes provided direct evidence against an alternative splicing of exon 3. In particular, this exon was retained into transcripts originating from the GHRfl-W16X allele in both the patient and his mother. These observations, given the normal phenotype of the heterozygous parents, revealed also that a single copy of either GHRfl or GHRd3 is sufficient for normal growth.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007334 Insulin-Like Growth Factor I A well-characterized basic peptide believed to be secreted by the liver and to circulate in the blood. It has growth-regulating, insulin-like, and mitogenic activities. This growth factor has a major, but not absolute, dependence on GROWTH HORMONE. It is believed to be mainly active in adults in contrast to INSULIN-LIKE GROWTH FACTOR II, which is a major fetal growth factor. IGF-I,Somatomedin C,IGF-1,IGF-I-SmC,Insulin Like Growth Factor I,Insulin-Like Somatomedin Peptide I,Insulin Like Somatomedin Peptide I
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008297 Male Males
D010375 Pedigree The record of descent or ancestry, particularly of a particular condition or trait, indicating individual family members, their relationships, and their status with respect to the trait or condition. Family Tree,Genealogical Tree,Genealogic Tree,Genetic Identity,Identity, Genetic,Family Trees,Genealogic Trees,Genealogical Trees,Genetic Identities,Identities, Genetic,Tree, Family,Tree, Genealogic,Tree, Genealogical,Trees, Family,Trees, Genealogic,Trees, Genealogical
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D011986 Receptors, Somatotropin Cell surface proteins that bind GROWTH HORMONE with high affinity and trigger intracellular changes influencing the behavior of cells. Activation of growth hormone receptors regulates amino acid transport through cell membranes, RNA translation to protein, DNA transcription, and protein and amino acid catabolism in many cell types. Many of these effects are mediated indirectly through stimulation of the release of somatomedins. Growth Hormone Receptors,Receptors, Growth Hormone,Somatomammotropin Receptors,Somatotropin Receptors,Growth Hormone Receptor,Receptor, Growth Hormone,Receptors, Somatomammotropin,Somatomammotropin Receptor,Somatotropin Receptor,Hormone Receptor, Growth,Hormone Receptors, Growth
D002461 Cell Line, Transformed Eukaryotic cell line obtained in a quiescent or stationary phase which undergoes conversion to a state of unregulated growth in culture, resembling an in vitro tumor. It occurs spontaneously or through interaction with viruses, oncogenes, radiation, or drugs/chemicals. Transformed Cell Line,Cell Lines, Transformed,Transformed Cell Lines
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D004854 Herpesvirus 4, Human The type species of LYMPHOCRYPTOVIRUS, subfamily GAMMAHERPESVIRINAE, infecting B-cells in humans. It is thought to be the causative agent of INFECTIOUS MONONUCLEOSIS and is strongly associated with oral hairy leukoplakia (LEUKOPLAKIA, HAIRY;), BURKITT LYMPHOMA; and other malignancies. Burkitt Herpesvirus,Burkitt Lymphoma Virus,E-B Virus,EBV,Epstein-Barr Virus,Human Herpesvirus 4,Infectious Mononucleosis Virus,Burkitt's Lymphoma Virus,HHV-4,Herpesvirus 4 (gamma), Human,Burkitts Lymphoma Virus,E B Virus,E-B Viruses,Epstein Barr Virus,Herpesvirus, Burkitt,Infectious Mononucleosis Viruses,Lymphoma Virus, Burkitt,Mononucleosis Virus, Infectious,Mononucleosis Viruses, Infectious

Related Publications

Jacques Pantel, and Jürgen Grulich-Henn, and Markus Bettendorf, and Christian J Strasburger, and Udo Heinrich, and Serge Amselem
January 1995, Journal of pediatric endocrinology & metabolism : JPEM,
Jacques Pantel, and Jürgen Grulich-Henn, and Markus Bettendorf, and Christian J Strasburger, and Udo Heinrich, and Serge Amselem
November 1991, Proceedings of the National Academy of Sciences of the United States of America,
Jacques Pantel, and Jürgen Grulich-Henn, and Markus Bettendorf, and Christian J Strasburger, and Udo Heinrich, and Serge Amselem
May 2012, Clinical endocrinology,
Jacques Pantel, and Jürgen Grulich-Henn, and Markus Bettendorf, and Christian J Strasburger, and Udo Heinrich, and Serge Amselem
December 2002, Reviews in endocrine & metabolic disorders,
Jacques Pantel, and Jürgen Grulich-Henn, and Markus Bettendorf, and Christian J Strasburger, and Udo Heinrich, and Serge Amselem
January 1998, Hormone research,
Jacques Pantel, and Jürgen Grulich-Henn, and Markus Bettendorf, and Christian J Strasburger, and Udo Heinrich, and Serge Amselem
June 2005, Arquivos brasileiros de endocrinologia e metabologia,
Jacques Pantel, and Jürgen Grulich-Henn, and Markus Bettendorf, and Christian J Strasburger, and Udo Heinrich, and Serge Amselem
January 2003, Journal of pediatric endocrinology & metabolism : JPEM,
Jacques Pantel, and Jürgen Grulich-Henn, and Markus Bettendorf, and Christian J Strasburger, and Udo Heinrich, and Serge Amselem
April 2008, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society,
Jacques Pantel, and Jürgen Grulich-Henn, and Markus Bettendorf, and Christian J Strasburger, and Udo Heinrich, and Serge Amselem
November 1997, The Journal of clinical endocrinology and metabolism,
Jacques Pantel, and Jürgen Grulich-Henn, and Markus Bettendorf, and Christian J Strasburger, and Udo Heinrich, and Serge Amselem
July 2021, The Journal of clinical endocrinology and metabolism,
Copied contents to your clipboard!